Aytu Biopharma (AYTU) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Aytu Biopharma (AYTU) over the last 6 years, with Q4 2025 value amounting to -$1.05.
- Aytu Biopharma's EPS (Weighted Average and Diluted) fell 27500.0% to -$1.05 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.2, marking a year-over-year decrease of 3483.15%. This contributed to the annual value of -$5.14 for FY2023, which is 9305.06% up from last year.
- Latest data reveals that Aytu Biopharma reported EPS (Weighted Average and Diluted) of -$1.05 as of Q4 2025, which was down 27500.0% from -$0.08 recorded in Q3 2025.
- Aytu Biopharma's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.21 during Q1 2025, with a 5-year trough of -$35.9 in Q1 2022.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$1.08 (2021), whereas its average is -$4.91.
- As far as peak fluctuations go, Aytu Biopharma's EPS (Weighted Average and Diluted) plummeted by 611714.29% in 2021, and later surged by 14038.46% in 2025.
- Over the past 5 years, Aytu Biopharma's EPS (Weighted Average and Diluted) (Quarter) stood at -$8.74 in 2021, then skyrocketed by 75.38% to -$2.15 in 2022, then surged by 105.11% to $0.11 in 2023, then plummeted by 354.55% to -$0.28 in 2024, then plummeted by 275.0% to -$1.05 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.05 for Q4 2025, versus -$0.08 for Q3 2025 and $0.21 for Q1 2025.